| Dear Fellow Trader, | | I hope you are having a great Friday and also hope you have a good weekend ahead of you! I am sending you the list of major stocks reporting Earnings before the market opens on the next trading day. So you can have enough time to trade Pre-Earnings strategy or hedge your existing position(s) before they report Earnings. It also includes '% Predicted Volatility After Earnings Announcement'. | NNVC: This Tiny Biotech Could Break Out in 2026 (ad)*
NanoViricides (NYSE: NNVC) is approaching a pivotal moment as its lead antiviral, NV-387, advances toward Phase II. Unlike traditional antivirals, NV-387 uses a nanoviricide platform designed to directly attack viruses while shielding organs from immune-related damage. It has shown remarkable survival benefits in humanized animal models and demonstrated strong safety in Phase I trials. With measles outbreaks rising and global viral threats expanding, NV-387's broad-spectrum potential—from influenza and RSV to MPox and smallpox—positions NNVC for major commercial traction. Two Phase II tracks, including an MPox trial in Congo and a multi-virus trial in India, set up a significant 2026 catalyst.
👉 Discover why NV-387 could become one of 2026's most important antiviral breakthroughs. | |  | Before Market Open |  | After Market Close | | | *Predicted Volatility % based on our Proprietary Volatility Predication Model. We are expecting that stock price will likely to reach % in either direction by the end of next trading session after Earnings are released and not necessarily the closing volatility %. | Why Top Traders Are Leaning on A.I. in Today's Market (ad)
Markets are more chaotic, politicized, and algorithm-driven than ever — and that's why elite traders rely on VantagePoint A.I. Its proprietary neural networks forecast trends days before they happen, with 87.4% verified accuracy across stocks, commodities, ETFs, and currencies. It correctly flagged gold's 50% launch past $4,000, while most analysts were still doubting the move. Now VantagePoint is hosting a free live training to reveal the next forecasted turning points — and the signals driving them.
🚀 Secure your seat now and see tomorrow's trends before the market reacts. | NNVC: The Under-the-Radar Biotech That Could Redefine Antiviral Therapy in 2026 (ad)*
NanoViricides (NYSE: NNVC) is advancing NV-387, a broad-spectrum antiviral that neutralizes viruses before they infect cells while protecting the lungs from immune-driven damage. With U.S. measles cases rising, NV-387 has shown 130% increased survival and strong lung protection in humanized models. Phase I trials confirmed safety, and its oral gummy formulation makes it patient-friendly during severe illness. NV-387's nanoviricide "Re-Infection Inhibition" technology targets measles, RSV, influenza, COVID-19, MPox, H5N1, and even smallpox—unlocking multi-billion-dollar global markets. Two Phase II tracks—a Congo MPox study and a multi-virus basket trial in India—position NNVC for major catalysts in 2026.
👉 Learn why NV-387 could be one of 2026's biggest antiviral breakthroughs. | | How to use Predicted Volatility in your trading strategies: | | Options Trading - You can use Volatility Rush strategies (buying straddle three weeks before earnings dates) for stocks which have more than 5% predicted volatility. Please click on Volatility Rush Trading Strategy to learn more about it. You can use Volatility Crush trading strategy for major stocks with Predicted Volatility less than 4%. Please click on Volatility Crush Strategy to learn more about it.You can use Ride-the-Wave to targets multi-day price momentum following a company's earnings announcement (EA). Please click on Ride-the-Wave Strategy to learn more about it. | | Stock Trading - If you're a stock trader or portfolio manager, you want to avoid an unexpected loss based on a surprise negative earnings announcement (you don't want to wake up on the morning of an earnings announcement and see your portfolio down by 10 percent or more). | | The key to avoiding this kind of loss is knowing a stock's historical earnings-related volatility well before it announces earnings. Armed with that knowledge, you'll have enough time to design a hedging strategy that will protect you from a big drop caused by a negative earnings announcement. | | At StockEarnings, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. | | To your trading success, | | Hiral Ghelani | | Founder & CEO | | StockEarnings, Inc | | 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | | W: 877.6.STOCKS (Mon to Sat | 9am to 5pm EST | Feel Free to Call Us) | | |
| | (ad)* This message is a PAID ADVERTISEMENT for NanoViricides, Inc (NYSE: NNVC) from Interactive Offers. StockEarnings, Inc. has received a fixed fee of $7000.00 from Interactive Offers for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between Nov 14, 2025 and Nov 20, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either NanoViricides, Inc (NYSE: NNVC) or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding NanoViricides, Inc (NYSE: NNVC) on Smallcaps Daily website for additional information about the relationship between Interactive Offers and NanoViricides, Inc (NYSE: NNVC). StockEarnings, Inc (SE) is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers. StockEarnings Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | W: 877.6.STOCKS | Unsubscribe
Today's Bonus Content: [Watchlist Alert] Small-Cap That Shocked Wall Street
| |
